AB Science will host a live webcast on June 3, 2021 following the voluntary hold in the clinical studies of masitinib

NEXT STORY
Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound LB-100 for Treatment of Small Cell Lung Cancer
PREV STORY
Novartis Kymriah® pivotal trial demonstrates strong response rates and a remarkable safety profile in relapsed or refractory follicular lymphoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results and Operational Highlights on March 1, 2021

author_avatar
NASDAQ Market News

Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020

author_avatar
NASDAQ Market News

Ziopharm Oncology Announces FDA Clearance of IND for Sleeping Beauty TCR-T Cell Therapy Trial at NCI

author_avatar
NASDAQ Market News